Programme recordUS-FDA-OPD

Funding Atlas programme

Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases

Programme note: RFA-FD-25-020, R01

FDA Office of Orphan Products Development

Funding typeGrantJurisdictionUnited StatesAreasRare disease

Documented facts

Key facts

Funder
FDA Office of Orphan Products Development
Programme
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
Programme note
RFA-FD-25-020, R01
Jurisdiction
United States
Funding type
Grant
Therapeutic areas
Rare disease

Source-bound timeline

Supplied dates

These dates were recorded in the Atlas as of 3 October 2026. Confirm current timing with the funder.

  1. Application Due Date (new applications)